Estimating long-term survival of PD-L1-expressing, previously treated, non-small cell lung cancer patients who received pembrolizumab in KEYNOTE-001 and -010 Meeting Abstract


Authors: Hellmann, M. D.; Ma, J.; Garon, E. B.; Hui, R.; Gandhi, L.; Soria, J. C.; Anderson, K. M.; Lubiniecki, G. M.; Piperdi, B.; Herbst, R. S.
Abstract Title: Estimating long-term survival of PD-L1-expressing, previously treated, non-small cell lung cancer patients who received pembrolizumab in KEYNOTE-001 and -010
Meeting Title: 2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 7 Suppl.
Meeting Dates: 2017 Feb 23-25
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-03-01
Language: English
ACCESSION: WOS:000443282900074
PROVIDER: wos
DOI: 10.1200/JCO.2017.35.7_suppl.77
Notes: Meeting Abstract: 77 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann